Current Category is: Diabetes | Select Another Category
Go Back To Category Homepage | View Category Sitemap
Free Information
Home   |   Search   |   Categories   |   Links   |   About Us   |   Contact Us


Pancreas Transplants - A Solution For Type 1 Diabetes Sufferers?


Type 1 diabetes was formerly known as juvenile diabetes or insulin dependent diabetes mellitus. Type 1 diabetes matures quickly and symptoms are very visible.

This type of diabetes occurs when the body's immune system destroys pancreatic cells. These cells are the insulin producing cells. This type of diabetes affects mostly children and young adults. Risk factors for type1 diabetes include autoimmune, genetics, and environmental factors.

Many clinical studies have shown that an option for type 1 diabetes treatment is the pancreas transplantation. For some patients, surgeons can restore the function of the pancreas with an islet cell transplant.

The most important benefit of pancreas transplantation is freedom from dependence on insulin. Although this is significant, this is not recommended treatment for diabetes unless there is a need for a kidney transplant as well.

On the other hand, pancreas transplants still remains problematic in that the immune system still can attack new pancreas cells. Some people who have transplants do find that the transplanted pancreas is attacked and the insulin-producing cells are killed off after operation.

At this time, pancreas transplants do not always provide permanent cures, and people who have transplants must take anti-rejection medication and immune-system suppressing drugs.

Many research teams are still working on this immune system problem that seems to be the root cause of type 1 diabetes (sometimes called auto-immune diabetes).

This is main reason that pancreas transplants are still only being studied experimentally and are not considered currently to be an automatic cure for all patients with type 1 diabetes.

Valerian, freelance writer specialized in health issues affecting men
http://www.mens-health-events.info/diabetes.php


MORE RESOURCES:

New York Daily News

Death Rate Dropping for People With Diabetes
WebMD
By Denise Mann May 22, 2012 -- New research shows that people with diabetes are living longer, and this is likely due to heart-healthy habits and tighter control of blood sugar levels. Many people may only associate diabetes with vision loss, ...
US Sees Drop in Deaths Linked to DiabetesU.S. News & World Report
Death rate drops among Americans with diabetes -CDCReuters
Study: People are living longer with diabetesNew York Daily News
MedPage Today -msnbc.com (blog) -MarketWatch (press release)
all 506 news articles »


Eli Lilly: Diabetes Drug Meets Cardiovascular Goals
Wall Street Journal
(LLY) said dulaglutide, an investigational treatment for Type 2 diabetes, met a primary endpoint for blood pressure and heart rate effects in a 16-week study. Dulaglutide, which is being studied as a once-weekly treatment for diabetes, was administered ...
Eli Lilly's diabetes drug meets mid-stage trial goalReuters
Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on ...PR Newswire (press release)
Lilly posts clean safety data on PhIII diabetes blockbuster hopefulFierceBiotech
NASDAQ
all 25 news articles »


Diabetes Drug Target Identified
Science Daily (press release)
ScienceDaily (May 21, 2012) — New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic. Patrick Tso, PhD, professor in the UC ...
Apofore Founder Publishes Studies Identifying Apolipoprotein A-IV as New ...MarketWatch (press release)

all 4 news articles »


The Guardian

Diabetes timebomb: Only half of NHS patients receiving acceptable care
The Independent
Sweeping variations in standards of care for diabetic patients is costing thousands of lives and wasting tens of millions of pounds every year, the government's spending watchdog reveals. Less than half the people with diabetes in England receive all ...
Diabetes care 'has been failing for decade'BBC News
Report reveals diabetes 'lottery'The Press Association
NHS failings lead to deaths of 24000 diabetics each year, says reportThe Guardian
ITV News -Get Bracknell -The Sun
all 7 news articles »


Medgadget.com

Diabetes Design Demo Day Semi-Finalist: N4A Diabetes Care Center
Medgadget.com
by Nicholas Genes on May 22, 2012 • 2:26 pm Among all the semi-finalists for Sanofi's Data Design Diabetes Demo Day, we think N4A Diabetes Care Center was the most unexpected and confusing. N4A dates back to 1960′s legislation on aging, and is a loose ...
Beaufort man advances to semifinals in diabetes innovation challengeHilton Head Island Packet

all 6 news articles »


A Sweet Life

Novo Nordisk diabetes drug gets broader approval
CBS News
NEW YORK — Danish drugmaker Novo Nordisk A/S said Tuesday that the Food and Drug Administration granted an additional marketing approval for its diabetes drug Levemir. Novo Nordisk says Levemir is now approved for use in children with type 1 diabetes ...
FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age ...MarketWatch (press release)
Novo Nordisk Diabetes Drug Approved For ToddlersInvestor's Business Daily
Novo Nordisk's Levemir Insulin Approved for Use in Children as Young as TwoA Sweet Life
Family Practice News Digital Network
all 15 news articles »


Diabetes class being offered in Fayette
Pittsburgh Tribune-Review
By Daily Courier Penn State Cooperative Extension, Fayette County, is offering a low-cost class titled "Dining with Diabetes: A Program for Adults with Diabetes and their Families" to teach those with type 2 diabetes how to manage their disease.



Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic ...
MarketWatch (press release)
BOSTON, May 22, 2012 /PRNewswire via COMTEX/ -- Rhythm announced today the results of a Phase 1b clinical trial of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis. The trial demonstrated that RM-131 greatly ...

and more »


Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For ...
MarketWatch (press release)
WESTPORT, Conn., May 22, 2012 /PRNewswire via COMTEX/ -- Valeritas, the maker of V-Go(TM) Disposable Insulin Delivery Device, a new, simple disposable device for the delivery of insulin designed especially for adults with type 2 diabetes, has selected ...

and more »


Medgadget.com

Diabetes Design Demo Day Semi-Finalist: GreenDot
Medgadget.com
by Nicholas Genes on May 22, 2012 • 12:38 pm Next up in our coverage of semi-finalists for Sanofi's Data Design Diabetes Demo Day is GreenDot, which used to be called Diabetes 3.0 (good idea on the name change, guys!) GreenDot was started by two UCSF ...


Google News

Home   |   Sitemap   |   Disclaimer   |   Privacy   |   Contact Us

© COPYRIGHT 2011 BRAINBELLY.COM